Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension

Circ Res. 2021 Jul 9;129(2):308-325. doi: 10.1161/CIRCRESAHA.120.318447. Epub 2021 May 13.

Abstract

[Figure: see text].

Keywords: arteries; hypertension; hypertrophy; myocytes, smooth muscle; receptors, angiotensin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / pharmacology*
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure / drug effects*
  • Case-Control Studies
  • Disease Models, Animal
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Female
  • HEK293 Cells
  • Humans
  • Hypertension / genetics
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Hypertension / prevention & control*
  • Immunoglobulin G / blood*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Middle Aged
  • Muscle, Smooth, Vascular / metabolism*
  • Muscle, Smooth, Vascular / physiopathology
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / metabolism
  • Rats
  • Receptor, Angiotensin, Type 1 / metabolism
  • Receptors, IgG / antagonists & inhibitors*
  • Receptors, IgG / genetics
  • Receptors, IgG / metabolism
  • Signal Transduction
  • Vascular Remodeling / drug effects

Substances

  • AGTR1 protein, human
  • Antibodies
  • Antihypertensive Agents
  • FCGR2B protein, human
  • Fcgr2b protein, mouse
  • Immunoglobulin G
  • Receptor, Angiotensin, Type 1
  • Receptors, IgG
  • Extracellular Signal-Regulated MAP Kinases